UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Daewoong teams up with ADM Korea to develop new drugs
Daewoong Pharmaceutical said Wednesday that the company has signed a memora...
by Shim Hyun-tai
|
2020-02-12 15:58
라인
Bridge Biotherapeutics, Konkuk University to develop back-eye diseases treatment
Bridge Biotherapeutics has agreed with Konkuk University to introduce techn...
by Lee Han-soo
|
2020-02-12 14:49
라인
GC’s sales rose but profits fell in 2019
GC said Wednesday it recorded sales of 1.36 trillion won ($1.1 billion) las...
by Lee Han-soo
|
2020-02-12 11:40
라인
Medipost’s sales edge up, losses widen last year
Medipost said Wednesday that the company’s operating and net losses magnifi...
by Lee Han-soo
|
2020-02-12 11:40
라인
MSD Korea workers unhappy with spinoff plan
After MSD announced its “strategy” to separate some medicines under a new c...
by Kim Yun-mi
|
2020-02-11 14:57
라인
Fake news about new coronavirus drug candidate goes viral
Dubious reports are circulating in Korea claiming that a Chinese research i...
by Kim Yun-mi
|
2020-02-11 12:33
라인
Novartis' new drug for mutated lung cancer gets insurance coverage
A combined modality therapy of Rafinlar (ingredient: dabrafenib) and Meqsel...
by Kim Yun-mi
|
2020-02-10 18:29
라인
Hanmi Pharmaceutical renews yearly profit records
Hanmi Pharmaceutical said that it recorded 1.11 trillion won ($937 million)...
by Shim Hyun-tai
|
2020-02-10 12:29
라인
Court acquits Nature Cell president of stock manipulation
The Seoul Southern District Prosecutor Office Friday acquitted Nature Cell ...
by Jeong Sae-im
|
2020-02-07 18:40
라인
Handok’s medicine for childhood hypophosphatasia gets insurance benefits
Handok's Strensiq (ingredient: asfotase alfa), a medicine for childhood...
by Kim Eun-young
|
2020-02-07 15:59
라인
AstraZeneca Korea leaves umbrella trade union
AstraZeneca Korea’s branch of the Korea Democratic Pharmaceutical Union sai...
by Jeong Sae-im
|
2020-02-07 14:35
라인
Experts caution against hasty use of Olumiant for new coronavirus
Although a British artificial intelligence (AI) developer said Eli Lilly’s ...
by Kim Yun-mi
|
2020-02-06 16:08
라인
MSD to spin off women’s health, biosimilars under new firm
MSD said it would concentrate on oncology drugs and vaccines and establish ...
by Kim Yun-mi
|
2020-02-06 13:07
라인
Helixmith presents study results of neuropathic pain treatment
Helixmith unveiled the outcome of its study on developing a treatment for p...
by Shim Hyun-tai
|
2020-02-05 18:43
라인
‘Baricitinib emerges as potential treatment for new coronavirus’
Benevolent AI, a U.K.-based artificial intelligence (AI) healthcare firm, h...
by Lee Han-soo
|
2020-02-05 16:32
라인
Medytox, Daewoong in final battle over BTX strain ownership
The legal dispute between Medytox and Daewoong Pharmaceutical over the sour...
by Jeong Sae-im
|
2020-02-05 12:41
라인
Interferon, Kaletra to get insurance benefit for new coronavirus treatment
The government said it would allow health insurance benefits for patients w...
by Kim Yun-mi
|
2020-02-04 16:39
라인
‘Gilead’s drug candidate effective to fight new coronavirus’
Gilead Sciences’ antiviral drug candidate, remdesivir, showed efficacy in t...
by Kim Yun-mi
|
2020-02-04 16:39
라인
Boryung Holdings sets up US offshoot
Boryung Holdings said that it has established a subsidiary, Hayan Health Ne...
by Lee Han-soo
|
2020-02-03 16:28
라인
Drug firms minimize gatherings, hospital visits as coronavirus fear spreads
The local pharmaceutical industry is canceling annual events and meetings a...
by Jeong Sae-im
|
2020-02-03 15:21
-
이전
11
12
13
14
15
16
17
18
19
20
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top